Trademark: 79075435
Word

Status
Dead
Status Code
404
Status Date
Tuesday, August 13, 2019
Serial Number
79075435
Registration Number
3960665
Registration Date
Tuesday, May 17, 2011
Mark Type
2000
Filing Date
Thursday, August 13, 2009
Published for Opposition
Tuesday, March 1, 2011
Cancellation Date
Tuesday, August 13, 2019

Trademark Owner History
Santaris Pharma A-S - Original Registrant

Classifications
1 chemicals for use in industry and science; active chemical ingredients for use in the manufacture of pharmaceuticals or pharmaceutical development candidates for treating infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemicals for use in the manufacture of medical and scientific preparations; nucleotides, nucleotide analogues and oligonucleotides for medical research and development
5 pharmaceutical preparations for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemical preparations for pharmaceutical, medical and therapeutic purposes, namely, for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system autoimmune diseases, genetic disorders and malignant diseases
42 scientific and technological services, namely, biopharmaceutical research as well as research and design connected thereto, namely, design and development of pharmaceutical products, biomedical and biotechnological analysis and research; development of medical and biomedical products and preparations; biochemical and molecular biological analysis; scientific, biotechnological and biomedical consultancy; in vivo and in vitro pre-clinical testing of potential pharmaceutical, medical preparations, methods and products
Color is not claimed as a feature of the mark.
The mark consists of a highly stylized double helix design.

Trademark Events
Mar 6, 2020
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Mar 6, 2020
Death Of International Registration
Dec 7, 2018
Total Invalidation Processed By The Ib
Sep 10, 2018
Total Invalidation Of Reg Ext Protection Sent To Ib
Sep 10, 2018
Invalidation Processed
Aug 22, 2018
Total Invalidation Of Reg Ext Protection Created
Dec 22, 2017
Cancelled Section 71
Nov 7, 2014
New Representative At Ib Received
Feb 24, 2013
Final Decision Transaction Processed By Ib
Oct 6, 2011
Final Disposition Notice Sent To Ib
Oct 5, 2011
Final Disposition Processed
Aug 17, 2011
Final Disposition Notice Created, To Be Sent To Ib
May 17, 2011
Registered-Principal Register
Mar 1, 2011
Published For Opposition
Feb 9, 2011
Notice Of Publication
Jan 25, 2011
Law Office Publication Review Completed
Jan 21, 2011
Assigned To Lie
Dec 22, 2010
Approved For Pub - Principal Register
Dec 21, 2010
Teas/Email Correspondence Entered
Dec 21, 2010
Correspondence Received In Law Office
Dec 21, 2010
Teas Request For Reconsideration Received
Jun 29, 2010
Final Refusal Mailed
Jun 29, 2010
Final Refusal Written
Jun 11, 2010
Teas/Email Correspondence Entered
Jun 11, 2010
Correspondence Received In Law Office
Jun 11, 2010
Teas Response To Office Action Received
Mar 23, 2010
Correction From The Ib Examined, No Action Is Needed
Mar 18, 2010
Correction Transaction Received From Ib
Jan 22, 2010
Refusal Processed By Ib
Dec 11, 2009
Non-Final Action Mailed - Refusal Sent To Ib
Dec 11, 2009
Refusal Processed By Mpu
Dec 11, 2009
Application Filing Receipt Mailed
Dec 10, 2009
Non-Final Action (Ib Refusal) Prepared For Review
Dec 9, 2009
Non-Final Action Written
Dec 7, 2009
Assigned To Examiner
Dec 7, 2009
New Application Office Supplied Data Entered In Tram
Dec 4, 2009
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24